Cullinan Therapeutics Overview
Cullinan Therapeutics Target Price
Analysts' 12-month price predictions for CGEM.
Get informed when a big investor buys or sells
+ FollowShare Price
$17.63
Average Target Price
$32.75
85.8% upside
85.8% upside4 analysts in the last 4 months
High: $37 | Low: $28
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-08 | Wedbush | $37 | 109.9% upside |  |
| 2026-04-28 | H.C. WainwrightRobert Burns | $30 | 70.2% upside | |
| 2026-03-11 | Wedbush | $36 | 104.2% upside | |
| 2026-03-10 | Stifel NicolausAlex Thompson | $28 | 58.8% upside | |
| 2026-02-02 | Guggenheim | $30 | 70.2% upside | |
| 2026-01-08 | H.C. Wainwright | $27 | 53.1% upside | |
| 2026-01-08 | Morgan Stanley | $30 | 70.2% upside | |
| 2025-12-09 | WedbushRobert Driscoll | $34 | 92.9% upside | |
| 2025-11-24 | BTIGJulian Harrison | $38 | 115.5% upside | |
| 2025-11-20 | New Street | $26 | 47.5% upside | |
| 2024-10-24 | UBSDavid Dai | $30 | 70.2% upside | |
| 2024-08-08 | Morgan StanleyJeffrey Hung | $38 | 115.5% upside | |
| 2024-05-16 | H.C. WainwrightEdward White | $28 | 58.8% upside | |
| 2024-04-17 | BTIGKaveri Pohlman | $30 | 70.2% upside | |
| 2024-04-16 | H.C. WainwrightEdward White | $29 | 64.5% upside | |
| 2023-02-03 | Morgan Stanley | $19 | 7.8% upside | |